1. Wolfe, F., Smythe, H.A. & Yunus, M.B. et al The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990; 33: 160-172.
2. McBeth, J. The epidemiology of chronic widespread pain and fibromyalgia. In: Wallace, D.J. & Clauw, D.J. (Eds.) Fibromyalgia & other central pain syndromes. Philadelphia: Lippincott, Williams & Wilkins, 2005: 17-28.
3. Clauw, D.J. The taxonomy of chronic pain: moving toward more mechanistic classifications. In: Wallace, D.J. & Clauw, D.J. (Eds.) Fibromyalgia and other central pain syndromes. Philadelphia: Lippincott, Williams & Wilkins, 2005: 9-16.
4. Giambardino, M.A., Affaitati, G., Lerza, R. & Delaurentis, S. Neurophysiological basis of visceral pain. J. Musculoskeletal Pain 2002: 10; ?: 151-163.
5. Hallegua, D.S. Fibromyalgia in inflammatory and endocrine disorders. In: Wallace, D.J. & Clauw, D.J. (Eds.) Fibromyaglia and other central pain syndromes. Philadelphia: Lippincott, Williams & Wilkins, 2005: 187-195.
6. Uceyler, N., Valenza, R., Stock, M. Schedel, R. Sprotte, G. & Sommer, C. Reduced Levels of anti-inflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 2006; 54; 8: 2656-2664
7. Mountz, J.M., Bradley, L.A. Modell, J.G. & Clauw, D.J. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995; 38: 926-938.
8. Yunus, M.B. The concept of central sensitivity syndromes. In: Wallace, D.J. & Clauw, D.J. (Eds.) Fibromyalgia & other central pain syndromes. Philadelphia: Lippincott, Williams & Wilkins, 2005: 29-44.
9. Staud, R. The Neurobiology of chronic musculoskeletal pain (including chronic regional pain). In: Wallace, D. & Clauw, D.J. (Eds.) Fibromyalgia and other central pain syndromes. Philadelphia: Lippincott, Williams & Wilkins, 2005: 45-62.
10. Rome, H.P. jr. & Rome, J.D. Limbically augmented pain syndrome (LAPS): kindling, corticolimbic sensitization and the convergence of affective and sensory symptoms in chronic pain disorders. Pain Medicine 2000; 1; 1: 7-23.
11. Kandel, E. From metapsychology to molecular biology: explorations into the nature of anxiety. Amer. J. of Psychiatry 1983; 140: 1277-1293.
12. Lawrence, R.C., Helmick, C.G. Arnett, F.C. & Clauw, D.J. Estimates of the Prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998; 41: 778-799.
13. Arnold, L.M., Hudson, J.I. & Hess, E.V. & Clauw, D.J. Family study of fibromyalgia. Arthritis Rheum. 2004; 50: 944-952.
14. McCain, G. A clinical overview of fibromyalgia syndrome. J. Musculoskeletal Pain 1996; 4; 1/2: 9-34.
16. Sprott, H. Muscles and peripheral abnormalities in fibromyalgia. In: Wallace, D.J. & Clauw, D.J. (Eds.) Fibromyalgia and other central pain syndromes. Philadelphia: Lippincott, Williams & Wilkins, 2005: 101-114.
3. Harvard Work Hours, Health, and Safety Group: Extended work shifts and the risk of motor vehicle crashes among interns. N Engl J Med. 2005 Jan 13;352(2):125-34.
5. Belenky G, Wesensten NJ, Thorne DR, et al: Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res. 2003 Mar;12(1):1-12
6. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. :The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003 Mar 15;26(2):117-26. Erratum in: Sleep. 2004 Jun 15;27(4):600.
7. Dinges DF, Pack F, Williams K, et al: Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night. Sleep 1997;20:267-277.
8) -Ewing SB, Balachandran DD, LeBeau L, et al: Subjective and objective indices of sleep loss: Effects of chronic partial sleep restriction. Sleep 2002;25:A448.
9. 52. Stutts JC, Wilkins JW, Osberg JS, et al: Driver risk factors for sleep-related crashes. Accid Anal Prev 2003;35:321-331
10. Spiegel K, Sheridan JF, Van Cauter E: Effect of sleep deprivation on response to immunization. JAMA 2002;288:1471-1472.
11. Ayas NT, White DP, Manson JE, et al: A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003;163:205-209.
12. Hobson J: Sleep. New York, Scientific American Library, 1989.
13. Smith, C. and Wong, P.T.P. 1991. Paradoxical sleep increases predict successful learning in a complex operant task. Behav. Neurosci. 105:282 -288.
14. Klein D, Moore R, Reppert S: Suprachiasmatic Nucleus: The Mind's Clock. New York, Oxford University Press, 1991.
17. Wagner DR , . Disorders of the circadian sleep-wake cycle. Neurol Clin 1996 Aug;14(3):651-70.
18. Bootzin RR: Stimulus control treatment for insomnia. Programs and abstracts of the 80th Annual Convention of the American Psychological Association; September 2, 1972; Honolulu, Hawaii.
19. Young T; Palta M; Dempsey J; Skatrud J; Weber S; Badr S , The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993 Apr 29;328(17):1230-5.
20. Nieto FJ; Young TB; Lind BK; Shahar E; Samet JM; Redline S; D'Agostino RB; Newman AB; Lebowitz MD; Pickering TG, Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000 Apr 12;283(14):1829-36.
21. Bixler EO, Vgontzas AN, Lin HM, et al: Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000;160:2289-2295.
22. Marin JM; Carrizo SJ; Vicente E; Agusti AG , Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005 Mar 19-25;365(9464):
23. Yaggi HK; Concato J; Kernan WN; Lichtman JH; Brass LM; Mohsenin V, Obstructive Sleep Apnea as a Risk Factor for Stroke and Death. N Engl J Med 2005 Nov 10;353(19):2034-2041.
x Chapter 4 | Interventional Treatments for Fibromyalgia and Other Pain Conditions
Dennis Dobritt, D.O.
SUGGESTED READINGS
Simons, David G., Travell, Janet G., and Simons, Lois S. Myofascial Pain and Dysfunction: The Trigger Point Manual. Philadelphia: Lippincott, 1999.
Starlanyl D, Copeland, Mary E., Fibromyalgia & Chronic Myofascial Pain - A Survival Manual. Oakland: New Harbinger, 2001.
Waldman, Steven D., Atlas of Pain Management Injection Techniques. Philadelphia: Sauders, 2000.
Waldman, Steven D., Atlas of Interventional Pain Management, 2nd Edition. Philadelphia: Saunders, 2004.
x Chapter 5 | Pharmacology Management of Fibromyalgia
Randy Schad, R.Ph.
1.Goldenberg DL, Burckhardt A, Crofford L, "Management of Fibromyalgia Syndrome", JAMA 2004;292:2388-2395.
2. Goodman & Gilman, The Pharmacological Basis of Therapeutics. 11th edition, McGraw Hill, New York, 2006:693.
7. Biasi G, Manaca S, Manganelli S, "Tramadol in the treatment of fibromyalgia syndrome:a controlled clinical trial versus placebo" Int J Clin pharmacol Res 1998:18:13-19.
8. Russell J, Kamin M, Bennett RM, "Efficacy of tramadol in treatment of pain in fibromyalgia" J clin Rheumatol 2000;6:250-257.
9. Bennett RM, Kamin M, Karin R "Tamadol and acetaminophen combination tablets in the treatment of fibromyalgia pain" Am J med 2003;114: 537-545.
10. Goodman & Gilman, The Pharmacological Basis of Therapeutics. 11th edition, McGraw Hill, New York, 2006:566
11. Micromedex, Thomson Healthcare, Inc. www.library.ucsf.edu/db/record.html?idrecord=82
12. Goodman and Gilmans The Pharmacological Basis of Therpeutics, McGraw Hill, New York, 2006 pages 566, 580.
13. Ibid
14. Ibid
15. Goldenberg DL, Burckhardt A, Crofford L, "Management of Fibromyalgia Syndrome", JAMA 2004;292:2388-2395.
16. Goodman & Gilman, The Pharmacological Basis of Therapeutics. 11th edition, McGraw Hill, New York, 2006:673
25. Carette S, McCain GA, Bell DA "Evaluation of amitriptyline in primary fibrositis" Arthritis Rheum 1986;29:655-659.
26. Goldenberg DL, Felson Dt, Dinerman HA Randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia" Arthritis Rheum 1986;29:1371-1377.
27. Carette S, Bell MJ, Reynolds WJ, "Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia:a randomized, double blind clinical trail" Arthritis Rheum 1994;37:32-40.p
28. Bennett RM, Gatter RA, Campbell SM "A comparison of cyclobenzaprine and placebo in the management of fibrositis" Arthritis Rheum 1988;31:1535-1542.
29. Tofferi JK,Jackson Jl, O'Malley PG"Treatment of fibromyalgia with cyclobenzaprine:a meta-anallysis" Arthritis Rheum 2004;51: 9-13.
30. Arnold LM,Keck PE "Antidepressant treatment of fibromyalgia:a meta-analysis and review" Psychosomatics 2000;41:104-113.
31.O'Malley PG, Balden E, Tomkins G "Treatment of fibromyalgia with antidepressants" J Gen Intern Med 2000;15:659-666.
35. Wolfe F, Cathery MA, Hawley DJA "Double-blind placebo controlled trial of fluoxetine in fibromyalgia" Scand J Rheumatol 1994;23:255-259.
36. Arnold LM, Hess EV, Hudson JL "Randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia" Am J Med 2002;112:191-197.
37. Goldenberg D, Mayskiy M, Mossey CJ "Randomized double-blind cross over trial of fluoxetine and amitriptylline in the treatment of filbromyalgia" Arthrits Rheum 1996;39:1852-1859.
38. Celiker R, Cagavi Z "Comparison of amitriptyline and sertraline in the treatment of fibromyalgia syndrome" (abstract Arthritis Rheum 2000; 43:s332.)
39. Gendreau RM, Mease PJ, Rao SR "Minacipran:a potential new treatment of fibromylalgia" (abstract) Arthritis Rheum 2003;48:s616.
40. Dwight MM, Arnold LM, O'Brien H "An open clinical trial of venlafaxine treatment of fibromyalgia" Psychosomatics 1998;39:14-17.
41. Sayar K, Aksu G, Ak L "Venlafaxine treatment of fibromyalgia" Ann Pharmacother 2003;37:1561-1565
42. Arnold LM, Lu Y, Crofford LJ "A double blind multicenter trial comparing duloxetine to placebo in the treatment of fibromyalgia with or without major depressive disorder. Arthritis Rheum 2004;50:2974-2984.
43. Arnold LM, Rosen A, Pritchett, Y"A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder" Pain 2005;119:5-15.
45. Crofford LJ, Rowbotham MC, Mease PJ "Pregablin for the treatment of Fibromyalgia sydrome:results of a randomized, double-blind, placebo-controlled trial" Arthritis Rheum 2005;52:1264-1273.
x Chapter 7 | Endocrine Dysfunction Concurrent with Fibromyalgia
Sander Paul, M.D.
1. Utiger RD. The thyroid: physiology, thyrotoxicosis, hypothyroidism and the painful thyroid. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001:261-347.
2. Ibid., 261-347
3. Woeber KA. Treatment of hypothyroidism. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 864-869.
4. Utiger RD. The thyroid: physiology, thyrotoxicosis, hypothyroidism and the painful thyroid. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001:261-347.
5. Braverman LE, Utiger RD. Introduction to hypothyroidism . In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005:697-699.
6. Ross DS. Disorders that cause hypothyroidism. UpToDate online version 13.1 www.uptodate.com, 2005.
7. Ross DS. Resistance to thyroid hormone, thyrotropin, and thyrotropin-releasing hormone. UpToDate online version 13.1 www.uptodate.com, 2005.
8. Ladenson, PW. Managment of hypothyroidism. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 857-863.
9. Braverman LE, Utiger RD. Introduction to hypothyroidism . In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005:697-699.
10. Ross DS. Diagnosis of and screening for hypothyroidism. UpToDate online version 13.1 www.uptodate.com, 2005.11. Ladenson, PW. Managment of hypothyroidism. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 857-863.
12. Ross DS. Laboratory assessment of thyroid function. UpToDate online version 13.1 www.uptodate.com, 2005.
13. Ladenson, PW. Managment of hypothyroidism. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 857-863.
14. Ross DS. Laboratory assessment of thyroid function. UpToDate online version 13.1 www.uptodate.com, 2005.
15. Utiger RD. The thyroid: physiology, thyrotoxicosis, hypothyroidism and the painful thyroid. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001:261-347.
16. Ross DS. Laboratory assessment of thyroid function. UpToDate online version 13.1 www.uptodate.com, 2005.
17. Utiger RD. The thyroid: physiology, thyrotoxicosis, hypothyroidism and the painful thyroid. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001:261-347.
18.Utiger RD. The thyroid: physiology, thyrotoxicosis, hypothyroidism and the painful thyroid. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001:261-347.
19. Ross DS Subclinical hypothyroidism. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 1070-1078
20.Ross DS. Treatment of hypothyroidism. UpToDate online version 13.1 www.uptodate.com, 2005.
21. Woeber KA. Treatment of hypothyroidism. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 864-869.
22. Ross DS. Treatment of hypothyroidism. UpToDate online version 13.1 www.uptodate.com, 2005.
23. Woeber KA. Treatment of hypothyroidism. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 864-869.
24. Ross DS. Treatment of hypothyroidism. UpToDate online version 13.1 www.uptodate.com, 2005.
25. Woeber KA. Treatment of hypothyroidism. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 864-869.
26. Wolfe F, Smythe HA, Yunus MB, etal. The American college of rehumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33;160-172.
27.Garrison RL, Breeding PC. A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses 2003, 61(2), 182-189.
28. Woeber KA. Treatment of hypothyroidism. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 864-869.
29. Bunnevicius R, Kazanavicus G, Zalinkevicius R, et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N. Engl J Med 1999; 424-429.
30. Ross DS. Treatment of hypothyroidism. UpToDate online version 13.1 www.uptodate.com, 2005.
32. Garrison RL, Breeding PC. A metabolic basis for fibromyalgia and its related disorders: the possible role of resistance to thyroid hormone. Med Hypotheses 2003, 61(2), 182-189.
33. Franklyn JA, Gammage MD. Morbidity and mortality in thyroid dysfunction and its treatment. In: Werner & Ingbar's the thyroid a fundamental and clinical text/editors , Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 1063-1078.
34. Ross DS. Bone disease with hyperthyroidism and thyroid hormone therapy. UpToDate online version 13.1 www.uptodate.com, 2005.
35. Subclinical thyrotoxicosis. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 1079-1085.
36. Shepard MC, Gittoes, NJL. The skeletal system in thyrotoxicosis. In: Werner & Ingbar's The thyroid a fundamental and clinical text/editors, Lewis Braverman, Robert Utiger- ninth edition, Lippincott Williams & Wilkins, 2005: 629-636.
37. Miller WL, Chrousos GP. The adrenal cortex. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001. 387-524.
38. Stewart PM. The adrenal cortex. In Williams textbook of endocrinology/editors P. Reed Larson, Henry Kronenberg, Shlomo Melmed, et al- tenth edition. Saunders, 2003:491-551.
39. Miller WL, Chrousos GP. The adrenal cortex. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001. 387-524.
40. Stewart PM. The adrenal cortex. In Williams textbook of endocrinology/editors P. Reed Larson, Henry Kronenberg, Shlomo Melmed, et al- tenth edition. Saunders, 2003:491-551.
41. Miller WL, Chrousos GP. The adrenal cortex. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001. 387-524.
42. Stewart PM. The adrenal cortex. In Williams textbook of endocrinology/editors P. Reed Larson, Henry Kronenberg, Shlomo Melmed, et al- tenth edition. Saunders, 2003:491-551.
43. Miller WL, Chrousos GP. The adrenal cortex. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001. 387-524.
44.Stewart PM. The adrenal cortex. In Williams textbook of endocrinology/editors P. Reed Larson, Henry Kronenberg, Shlomo Melmed, et al- tenth edition. Saunders, 2003:491-551.
45. Miller WL, Chrousos GP. The adrenal cortex. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001. 387-524.
46. Stewart PM. The adrenal cortex. In Williams textbook of endocrinology/editors P. Reed Larson, Henry Kronenberg, Shlomo Melmed, et al- tenth edition. Saunders, 2003:491-551.
47. Miller WL, Chrousos GP. The adrenal cortex. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001. 387-524.
48. Stewart PM. The adrenal cortex. In Williams textbook of endocrinology/editors P. Reed Larson, Henry Kronenberg, Shlomo Melmed, et al- tenth edition. Saunders, 2003:491-551.
49. Miller WL, Chrousos GP. The adrenal cortex. In:Endocrinology and metabolism/ editors Philip Felig. Lawrence Frohman, -fourth edition, McGraw-Hill, 2001. 387-524.
50. Stewart PM. The adrenal cortex. In Williams textbook of endocrinology/editors P. Reed Larson, Henry Kronenberg, Shlomo Melmed, et al- tenth edition. Saunders, 2003:491-551.
51.Adler GK. HPA Axis and Fatigue. Presented at the 2005 Endocrine Society Meeting, San Diego, CA, June 2005.
52. Adler GK, Kinsley B, Hurwitz S, Mossey CJ, Goldenberg, DL. Reduced hypothalamic-pituitary and sypathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med. 1999;106:534-543.
53. Adler GK. HPA Axis and Fatigue. Presented at the 2005 Endocrine Society Meeting, San Diego, CA, June 2005.
x Chapter 8 | Temporomandibular Disorders (TMD) and Facial Pain
Ghabi Kaspo, D.D.S.
1. Anderson, H. I., Ejlerstsson, G. & Rosenberg, C. (1993). Chronic pain in a geographically defined general population: studies of differences in age, gender, social, class and pain localization. Clin J Pain, 9, 174-182.
Additional references:
Badley EM, Rasooly I, Webster GK,: Relative importance of Musculoskeletal disorders as a cause of chronic health problems, disability and health care utilization: Fidings from the 1990 Ontario Health Survey. J Rheumatology 21:505-514, 1994
Anderson HI, Ejlerstsson G, and Rosenberg C: Chronic pain in a geographically defined general population: studies of differences in age, gender, social, class and pain localization. Clin J Pain 9:174-182, 1993.
Primary Fibromyalgia Syndrome in TMD Patients; G.A. Kaspo; - Based on a clinical study conducted on approximately 460 patients presented to the Center for TMJ Disorders and Orofacial Pain Management; 1994 Poster Clinics, Chicago IL, AAOP Annual Meeting.
TMJ: Its many faces: Wesley E. Shankland II, 2nd Edition
Orofacial Pain, The American Academy of Orofacial Pain, Edited by Jeffery Okeson
x Chapter 9 | Irritable Bowel Syndrome (IBS) Concurrent with Fibromyalgia
1. Whitehead, W. E., Palsson, O. & Jones, K. R. (2002). Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?
2. Drossman, D. A., Camilleri, M., Mayer, E. A. & Whitehead, W. E. (2002). AGA technical review on irritable bowel syndrome. Gastroenterology, 123, 2108-2131.
3. Russo, M. W., Gaynes, B. N. & Drossman, D. A. (1999). A national survey of practice patterns of gastroenterologists with comparison to the past two decades. Journal of Clinical Gastroenterology, 29, 339-43.
4. Heitkemper, M. M., Jarrett, M., Bond, E. F. & Chang, L. (2003). Impact of sex and gender on irritable bowel syndrome. Biological Research for Nursing, 5(1), 56-65.
5. Palsson, O.S. & Drossman, D.A. (2005). Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterology Clinics of North America,34(2), 281-303.
6. Whitehead, W. E. & Palsson, O. S. (1998). Is rectal pain sensitivity a biological marker for irritable bowel syndrome: Psychological influences on pain perception. Gastroenterology 115, 1263-71.
7. Posserud, I., Ersryd, A., & Simren, M. (2006). Functional findings in irritable bowel syndrome. World Journal of Gastroenterology, 12(18), 2830-8.
8. Ringel, Y. (2002). Brain research in functional gastrointestinal disorders. Journal of Clinical Gastroenterology, 35(Supplement 1), S23-5.
9. Crowell, M. D. (2004). Role of serotonin in the pathophysiology of the irritable bowel syndrome. British Journal of Pharmacology 141(8), 1285-93.
10. Wood, J. D. (2002). Neuropathophysiology of irritable bowel syndrome. Journal of Clinical Gastroenterology 35 (Supplement 1),S11-22.
11. Rhodes, D. Y. & Wallace, M. (2006). Post-infectious irritable bowel syndrome. Current Gastroenterology Reports, 8(4),327-32.
12. Neal, K.R., Barker, L. & Spiller, R. C. (2002). Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut, 51(3), 410-3.
14. Drossman, D. A. (1999). Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? American Journal of Medicine, 107(5A), 41S-50S.
15. Levy, R. L., Von Korff, M., Whitehead, W. E., Stang, P., Saunders, K., Jhingran, P. et al. (2001). Costs of care for irritable bowel syndrome patients in a health maintenance organization. American Journal of Gastroenterology, 96, 3122-3129.
16. Sandler, R. S., Everhart, J. E., Donowitz, M., Adams, E., Cronin, K., Goodman, C. et al. (2002). The burden of selected digestive diseases in the United States. Gastroenterology, 122, 1500-1511.
17. Miller, V., Hopkins, L. & Whorwell, P. J. (2004). Suicidal ideation in patients with irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 2(12), 1064-8.
18. Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B. & Mayer E.A. (2000). The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology, 119(3), 654-60.
19. Lubrano, E., Iovino, P., Tremolaterra, F., Parsons, W. J., Ciacci, C. & Mazzacca, G. (2001). Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder. International Journal of Colorectal Diseases, 16(4), 211-5.
20. Wessely, S., Nimnuan, C. & Sharpe, M. (1999). Functional somatic syndromes: one or many? Lancet, 354(9182), 936-9.
21. Lubrano, E., Iovino, P., Tremolaterra, F., Parsons, W.J., Ciacci, C., & Mazzacca, G. (2001). Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder. International Journal of Colorectal Disease, 16(4),211-5.
22. Sperber, A. D., Atzmon, Y., Neumann, L., Weisberg, I., Shalit, Y., Abu-Shakrah, M., Fich, A. & Buskila, D. (1999). Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. American Journal of Gastroenterology, 94(12), 3541-6.
23. Chang, L., Berman, S., Mayer, E. A., Suyenobu, B., Derbyshire, S., Naliboff, B., Vogt, B., FitzGerald, L. & Mandelkern, M. A. (2003). Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. American Journal of Gastroenterology, 98(6), 1354-61.
24. Chang, L., Mayer, E. A., Johnson, T., FitzGerald, L. Z. & Naliboff, B. (2000). Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain, 84(2-3), 297-307.
25. Whitehead, W. E., Levy, R. L., Von Korff, M. V, Feld, A. D., Palsson O.S., Turner M.J. & Drossman, D. A. (2004). Usual medical care for irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 20, 1305-1315.
26. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force. (2002). Evidence-based position statement on the management of irritable bowel syndrome in North America. American Journal of Gastroenterology. 97, S1-S5.
27. Talley NJ. (2003). Evaluation of drug treatment in irritable bowel syndrome. British Journal of Clinical Pharmacolology, 56(4),362-9.
28. Thompson, W. G., Heaton, K. W., Smyth, G. T. & Smyth, C. (1997). Irritable bowel syndrome: the view from general practice. European Journal of Gastroenterology & Hepatology, 9, 689-692.
29. Gonsalkorale, W. M., Houghton, L. A., & Whorwell, P. J. (2002). Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness.
American Journal of Gastroenterology, 97(4), 954-61.
x Chapter 10 | Acupuncture in the Management of Fibromyalgia
1. Cho & Zang-Hee. (2002). Presentation at American Academy of Medical Acupuncture.
2. Mussat & Maurice, translated by Serejski, E. (1997). Physiological Energetics of Acupuncture. Orig. 1979, Librairie Le Francois, France.
3. Stux, G. & Pomeranz, B. (1989). Springer-Verlag, Berlin. Acupuncture: Textbook and Atlas.
x Chapter 11 | Visual Problems Concurrent with Fibromyalgia
Randy Houdek, O.D.
1. Pellegrino, Mark M.D. ImmuneSupport. com Treatment & Research Information, Prescribed Medications for Fibromyalgia: 02-06-2002
6. Murphy, John, Dry Eye: Signs vs. Symptoms. Review of Optometry, June 2004:53-61
7. Byrne, Jennifer, Investigational Dry Eye Drugs Address the Disease on Several Levels. Primary Care Optometry News, November 2005:16 revoptom.com/index.asp?page=2_1483.htm
1. Yunus, M.B. The concept of central sensitivity syndromes In: Wallace, D.J. & Clauw, D.J. (Eds.) fibromyalgia and other central pain syndromes. Philadephia: Lippincot, Williams & Wilkins, 2005: 29-44.
2. Martinez-Lavin, M. Dysfunction of the autonomic nervous system in chronic pain syndromes In: Wallace, D.J. & Clauw, D.J. (Eds.) Fibromyalgia and other central pain syndromes. Philadelphia: Lippincot, Williams & Wilkins, 2005: 81-87.
3. Cooke, J.P., Creager, M.A. Osmundson, P.J., & Shepherd, J.T. Sex differences in control of cutaneous blood flow. Circulation 1990; 82: 1607-1615.
4. Westlund, K.N. Neurophysiology of nociception In: Pappagallo, M. (Ed.) The neurological basis of pain. New York: McGraw Hill, 2005: 3-19.
5. Giambardino, M.A., Affaitati, G., Lerza, R. & De Laurentis, S. Neurophysiological basis of visceral pain. J. Musculoskeletal Pain 2002; 10: 1/2: 151-163.
6. Graceley, R.H. & Bradley, L.A. Functional imaging of pain. In: Wallace, D.J. & Clauw, D.J. (Eds.) Fibromyagla and other central pain syndromes. Philadelphia: Lippincot, Williams & Wilkins, 2005: 89-100
7. Arnold, L. Systemic therapies for chronic pain. In: Wallace, D.J. & Clauw, D.J. (Eds.) Fibromyalgia and other central pain syndromes. Philadelphia: Lippincot, Williams & Wilkins, 2005: 365-388.
8. Gracely, R.H., Petzke, F. Wolf,, J.M. & Clauw, D.J. Functional MRI evidence of Augmented pain processing in fibromyalgia. Arthritis Rheum, 2002; 46: 1333-1343.
9. Hoffer, M.J. The neurophysiology of pain. In: Aronoff, G.M. (Ed.) Evaluation and treatment of chronic pain. Baltimore: Williams & Wilkins, 1992: 10-25.
10. Yerkes, R.M. & Dodson, J.D. The relation of strength of stimulus to rapidity of habit formation. J. of Comparative and Neurology and Psychology, 1908; 18: 459-482.
11. Coluzzi, F. & Mattia, C. Antidepressants, anticonvulsants and miscellaneous Agents In: Pappagallo, M. (Ed.) The neurological basis of pain. New York: McGraw Hill, 2005: 581-598.
13. Kubler-Ross, E. On death and dying. New York: Simon & Schuster, 1993.
14. Averill, J. Anger and aggression. An essay on emotion. New York: Springer-Verlag, 1982.
15. Culver, M.D. & Kell, M.J. Working with chronic pain patients: spirituality as part of the treatment protocol. Amer. J of Pain Management, 1995; 5; 2: 55-61.
16. Surwit, R.S., Williams, R.B. Jr. & Shapiro, D. Behavioral Approaches to Cardiovascular Disease. New York: Academic Press, 1982.
17. Gracely, R.H., Geisser, M.E., Geisecke, T. & Clauw, D.J. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain, 2004; 127 (4): 835-843.
18. Sternbach, R.A. Pain and Ôhassles' in the United States: findings of the Nuprin report. Pain, 1986; 27 (1): 69-80.
19. Krystal, H. Integration & self-healing, affect, trauma alexithymia. Hillsdale: The Analytic Press, 1988.
x Chapter 13 | ADHD and Fibromyalgia: Related Conditions?
1. Aaron, L.A., Buchwald, D. A review of the evidence for overlap among unexplained conditions. Annals of Internal Medicine, (2001);134:868-81.
2. Adler, G.K., Valdis, F.M. and Creskoff, K.W. (2002). Neuroendocrine abnormalities in fibromyalgia. Pain and Headache Reports, 6:289-298.
4. American Psychiatric Press (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: American Psychiatric Association.
5. Arnold, L.M., Hess, E.V., Hudson, J.I., Welge, J.A., Berno, S.E., Keck, P.E., Jr. American Journal of Medicine, 2002;112(3).
6. Barkley, R.A. Attention-deficit hyperactivity disorder. Scientific American. September 1998;66-71.
7. Barkley, R.A. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 2nd Ed. New York, NY: The Guilford Press: 1996: 201-224.
x Chapter 15 | Physical Therapy Evaluation and Treatment of Fibromyalgia
1. Bennett, Robert M. The Clinical Neurobiology of Fibromyalgia and Myofascial Pain: Therapeutic Implications. Binghamton, NY: The Haworth Medical Press, 2002.
2. Michlovitz, Susan L., and Thomas P. Nolan Jr. Modalities for Therapeutic Intervention. Philadelphia, PA: F.A. Davis Company, 2005.
3. Clark, Sharon R. "Prescribing Exercise for Fibromyalgia Patients." Arthritis Care and Research. December 1994: 221-225.
4. Travell, Janet G., and David G. Simons. Myofascial Pain and Dysfunction: The Trigger Point Manual, The Upper Extremities. Vol. 1. Baltimore, MD: Williams & Wilkins, 1983.
x Chapter 19 | Nutrition & Healing
Sharon Ostalecki, Ph.D.
6. Insel, P.,Turner, R., & Ross, D. Discovering Nutrition. Jones and Bartlett Publishing, 2006:222-223
7. Skelly, M., Helm, A. Alternate Treatments for Fibromyalgia & Chronic Fatigue Syndrome. Alameda, CA. Hunter House Inc., 1999:120.
8. Waterhouse, J.C., Ph.D. Food Allergy/Sensitivity: The Pulse Test and Other Strategies. CISRA's Synerfy Health Newsletter, Issue 5, Vol.2(2), Summer/Fall, 1999.
9. Simons, DG, Travell, JG., & .Myofascial Pain & Dysfunction: The Trigger Point Manual-The Upper Extremities. 2nd Ed. Williams & Wilkins, Copyright 1983:114
x Chapter 22 | Behaviorally Reconnecting Mind & Body
Donald Moss, Ph. D.
1. Quintner, J. (1992). Fibromyalgia: The Copenhagen declaration. Lancet, 340 (8827):1103
2. Donaldson, C. C. S., Sella, G. E., & Mueller, H. H. (1998). Fibromyalgia: A retrospective study of 252 consecutive referrals. Canadian Journal of Clinical Medicine, 5(6), 116-127.
3. Perlis, M. L., Giles, D. E., Bootzin, R. R., Dikman, Z. V., Fleming, G. M, Drummond, S. P., & Rose, M. W. (1997). Alpha sleep and information processing, perception of sleep, pain and arousability in fibromyalgia. International Journal of Neuroscience, 80(3-4), 265-280.
4. Cohen, H., Neumann, L., Shore, M., Amir, M., Cassuto, Y., & Buskila, D. (2000). Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability. Seminars in Arthritis and Rheumatism, 29(4), 197-9, and Martinez-Lavin, M., Hermosillo, A.G., Rosas, M., & Soto, M.E. 1998). Circadian studies of autonomic nervous balance in patients with fibromyalgia: A heart rate variability analysis. Arthritis and Rheumatology, 41(11), 1966-71, and Vaeroy, H. (1989). Altered sympathetic nervous system response in patients with fibromyalgia. Journal of Rheumatology, 16(11), 1460-1465.
5. Drexler, A. R., Mur, E.J., & Gunther, V.C. (2002). Efficacy of an EMG-biofeedback therapy in fibromyalgia patients. A comparative study of patients with and without abnormality in (MMPI) psychological scales. Clinical and Experimental Rheumatology, 20(5), 677-82, Mur E., Drexler, A., Gruber, J., Hartig, F., & Gunther, V. (1999). Electromyography biofeedback therapy in fibromyalgia. Wiener medizinische Wochenschrift, 149(19-20), 561-3, and Donaldson, C.C.S., & Sella, G. (2003). Fibromyalgia. In D. Moss, A. McGrady, T. Davies, & I. Wickramasekera (Eds.), Handbook of mind body medicine for primary care (pp. 323-332). Thousand Oaks, CA: Sage.
6. Gilbert, C., & Moss, D. (2003). Biofeedback. In D. Moss, A. McGrady, T. Davies, & I. Wickramasekera (Eds.), Handbook of mind body medicine for primary care (pp. 109-122). Thousand Oaks, CA: Sage.
7. Jacobson, E. (1938). Progressive relaxation. Chicago: University of Chicago Press.
8. Moss, D. (2004). Heart rate variability and biofeedback. Psychophysiology Today: The Magazine for Mind-Body Medicine, 1, 4-11.
Available online at www.bfe.org/library.html
9. DelPozo, J., Gevirtz, R.N., Scher, B., & Guarneri, E. (2004). Biofeedback treatment increases heart rate variability in patients with known coronary artery disease. American Heart Journal, 147(3), E11.
10. Cohen, H., Neumann, L., Shore, M., Amir, M., Cassuto, Y., & Buskila, D. (2000). Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability. Seminars in Arthritis and Rheumatism, 29(4), 197-9, Martinez-Lavin, M., Hermosillo, A.G., Rosas, M., & Soto, M.E. 1998). Circadian studies of autonomic nervous balance in patients with fibromyalgia: A heart rate variability analysis. Arthritis and Rheumatology, 41(11), 1966-71, Raj, S. R., Brouillard, D, Simpson, C.S., Hopman, W.M., & Abdollah, H. (2000). Dysautonomia among patients with fibromyalgia: A noninvasive assessment. Journal of Rheumatology, 27(11), 2660-5.
11. Sisto, S. A., Tapp, W., Drastal, S., Bergen, M., DeMasi, I., Cordero, D., & Natelson, B. (1995). Vagal tone is reduced during paced breathing in patients with the chronic fatigue syndrome. Clinical Autonomic Research, 5(3), 139-143.
12. Gevirtz, R. N. (2003). The promise of HRV biofeedback: Some preliminary results and speculations. Biofeedback, 31(3), 18-19, Gevirtz, R. N. (2000). Resonant frequency training to restore homeostasis for treatment of psychophysiological disorders. Biofeedback, 27, 7-9, and Radvanski, D., Vaschillo, E. G., Vaschillo, B., Hassett, A. L., Lehrer, P. M., & Sigal, L. (2004, April). Heart rate variability biofeedback for fibromyalgia treatment. Paper presented to the annual meeting of the Association for Applied Psychophysiology and Biofeedback, Austin, TX.
13. Gruzelier, J. (2002). A review of the impact of hypnosis, relaxation, guided imagery and individual differences on aspects of immunity and health. Stress, 5(2):147-63, and Lehrer, P.M., & Woolfolk, R.L. (Eds.) (1993). Principles and practice of stress management (2nd edition). New York: Guilford Press.
14. Davis, M., Eshelman, E. R., & McKay, M. (2000). Relaxation and stress reduction workbook. Oakland, CA: New Harbinger Workbooks, and Lehrer, P. M., & Carrington, P. (2003). Relaxation, autogenic training, and meditation. In D. Moss, D., I. Wickramasekera, A. McGrady, & T. Davies (Eds.), Handbook of mind-body medicine in primary care (pp. 137-149). Thousand Oaks, CA: Sage.
15. Buckelew, S.P., Conway, R., Parker, J., Deuser, W.E., Read, J., Witty, T.E., Hewett, J.E., Minor, M., Johnson, J.C., Van Male, L., McIntosh, M.J., Nigh, M., & Kay, D.R.. (1998). Biofeedback/relaxation training and exercise interventions for fibromyalgia: A prospective trial. Arthritis Care and Research, 11(3), 196-209.
16. Keel, P. J., Bodoky, C., Gerhard, U, & Muller, W. (1998). Comparison of integrated group therapy and group relaxation training for fibromyalgia. Clinical Journal of Pain, 14(3),232-8.
17. Haanen HC, Hoenderdos HT, van Romunde LK, Hop WC, Mallee C, Terwiel JP, Hekster GB. (1991). Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. Journal of Rheumatology, 18(1), 72-75.
18. LaVaque, T. (2003). Neurofeedback, neurotherapy, and quantitative EEG. In D. Moss, A. McGrady, T. Davies, & I. Wickramasekera (Eds.), Handbook of mind body medicine for primary care (pp. 123-135). Thousand Oaks, CA: Sage.
19. Moss, D., McGrady, A., Davies, T., & Wickramasekera, I., (Eds.). (2003). Handbook of mind-body medicine in primary care. Thousand Oaks, CA: Sage Publications.
20. Gordon, J. S., & Moss, D. (2003). Manifesto for a new medicine. Biofeedback, 31(3), 8-11, 19.
Home | About | The Book | Reviews | Our Privacy Policy | Contact Us | Site Map